<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20161022030424N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-04-23</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of anti-inflammatory compared with the low-calorie diet on anthropometric indecies, anxiety, depression, functional status, pain and quality of life and serum indices of inflammation and oxidative stress in overweight and obese women with knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>The effect of anti-inflammatory compared with the low-calorie diet on anthropometric indecies, anxiety, depression, functional status, pain and quality of life and serum indices of inflammation and oxidative stress in overweight and obese women with knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/30089</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization to a low-calorie diet or an anti-inflammatory diet was done by an allocation sequence specified by computerized random-number generation (Blockrand in R version 3.4.0; R Project for Statistical Computing) by a statistician not included in intervention delivery or data collection, Blinding description: Participants did not learn of their diet group assignment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Balanced diet (A) intervention to reduce the weight of half a kilogram a week will be deducted from the average 3-day energy received by the individual 500 kilocalories and the diet will be designed with the following distribution: Fat: Less than 30% calories, Carbohydrates: 60-55 Percentage of calories and protein: 10-15% calories. Intervention 2: Intervention group 2: Anti-inflammatory Diet Intervention (B)The anti-inflammatory diet on fresh fruits and vegetables is the largest portion of the diet that should be eaten in large amounts and in each meal, in different types and colors (two-thirds of dietary calories).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Neda Dolatkhah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Reza Hospital, Golgasht, Azadi Ave.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614756</zip>
        <telephone>+98 41 3336 1928</telephone>
        <email>dolatkhahn@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Neda Dolatkhah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Reza Hospital, Golgasht, Azadu Ave.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614756</zip>
        <telephone>+98 41 3336 1928</telephone>
        <email>dolatkhahn@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of knee osteoarthritis by physicians (mild, moderate)
Age 50 and older
BMI 41-27
Has the cognitive ability to complete the learned forms of food
The desire to participate in the study</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Get daily calories less than 800 and more than 4200 kcal
Follow a special food pattern for medical reasons or other reasons
Infection with other inflammatory diseases, such as rheumatoid arthritis
Diabetes
Other musculoskeletal problems, including back pain
Having a history of radiotherapy
Intra-articular intra-articular injection 3 months ago
Oral use (nonsteroidal anti-inflammatory drugs) from a week before entering the study
Depression (gaining a score of more than 5 from the Geriatric Depression Scale, GDS-15)
History of neurological diseases or drug use
People who for any reason are not able to cooperate in completing questionnaires and plans
Use of dietary supplements, diuretics or laxatives during the intervention period
Participate in sports programs or change physical activity
Performing physiotherapy in the last 3 months
Use of nonsteroidal anti-inflammatory drugs during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unilateral primary osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Balanced diet (A) intervention to reduce the weight of half a kilogram a week will be deducted from the average 3-day energy received by the individual 500 kilocalories and the diet will be designed with the following distribution: Fat: Less than 30% calories, Carbohydrates: 60-55 Percentage of calories and protein: 10-15% calories.</i_keyword>
      <i_keyword>Intervention group 2: Anti-inflammatory Diet Intervention (B)The anti-inflammatory diet on fresh fruits and vegetables is the largest portion of the diet that should be eaten in large amounts and in each meal, in different types and colors (two-thirds of dietary calories).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Functional status and pain associated with osteoarthritis in the lower extremities. Timepoint: Before and after the intervention. Method of measurement: Western Ontario and McMaster (WOMAC).</prim_outcome>
      <prim_outcome>BMI. Timepoint: The beginning and the end of the study. Method of measurement: The result of dividing the weight into kilograms by squared height in meters.</prim_outcome>
      <prim_outcome>Waist. Timepoint: The beginning and the end of the study. Method of measurement: Strip meter.</prim_outcome>
      <prim_outcome>Hip circumference. Timepoint: The beginning and the end of the study. Method of measurement: Strip meter.</prim_outcome>
      <prim_outcome>Severity of anxiety. Timepoint: The beginning and the end of the study. Method of measurement: Two-part questionnaire of Spielberger's apparent and hidden anxiety.</prim_outcome>
      <prim_outcome>Depression rate. Timepoint: The beginning and the end of the study. Method of measurement: Beck Depression Inventory.</prim_outcome>
      <prim_outcome>The amount of pain. Timepoint: The beginning and the end of the study. Method of measurement: VAS (Visual Analogue Scale).</prim_outcome>
      <prim_outcome>Quality of Life. Timepoint: The beginning and the end of the study. Method of measurement: SF-36 quality of life questionnaire.</prim_outcome>
      <prim_outcome>Biochemical analysis of blood samples. Timepoint: The beginning and the end of the study. Method of measurement: Biochemical analysis of blood samples.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-02-26</approval_date>
        <contact_name>Ethics Committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Tabriz University of Medical Sciences, Golgshest St, Azadi St,Tabriz Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
